Two Player Mode:
You play with a friend (or just some person that is not necessarily your friend; it really doesn’t matter). The game is over when one of you succeeds in getting five balls past your opponent.
One Player Survival Mode:
You play against our AI. The game is over when one of you succeeds in getting five balls past your opponent… Good luck winning against our impossible mode.
One Player Score Mode:
You still play against our AI, but this time the game ends when just a single ball gets past your paddle. Your score increases, the longer you last and increases faster if there are more balls in play and if the balls are moving faster.
Changing Ball Speed:
Before every game, you have the choice of setting the balls to one of four speeds: Slow, Normal, Fast, and Very Fast.
Changing Ball Number:
You can choose between having 1, 2, 3, and A Lot of balls (a lot means that there is no limit to the balls).
Changing AI Level:
You can choose between playing against the Easy, Medium, Hard, and Impossible AIs.
Extra game play modes when you upgrade to the premium version:
Max Balls Mode: You try and keep as many balls in play as possible. You lose if one gets past you.
Custom Mode: You can adjust the sizes of yours and your opponent’s paddles. You can also adjust the amount of points you and your opponent each need to win.
No ads: The premium version gets rid of the ads and also helps support our non-profit organization!
This game is brought to you by Aiding Hearts, a nonprofit corporation raising money for research and awareness of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy, an incurable heart disease. ARVD/C is a genetic defect and causes the patient’s cardiac muscle to gradually turn into fatty tissue. It gets worse the faster and more irregular the patient’s heart beats and thus imposes stringent physical limitations. It is a difficult disease to detect until there is a substantial amount of progress and it usually first manifests itself as a tachycardia, similar to a heart attack, as happened to our CEO and founder Max Horland. Estimates for how many have this disease ranges from 1 in 2000 people to 1 in 5000 people, but it accounts for over 35% of sudden cardiac arrest in young athletes. Currently many doctors aren’t even aware of its existence and there is very little research (and funding for research) devoted to it. We hope to change that.